(5E,8E)-十四碳-5,8-二烯酸 | 10390-16-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: (5E,8E)-十四碳-5,8-二烯酸
• 英文名称: 5,8-Tetradecadienoic acid
• 英文别名: (5E,8E)-tetradeca-5,8-dienoic acid
• CAS: 10390-16-6
• 化学式: C₁₄H₂₄O₂
• 分子量: 224.34
• InChiKey: HXHZGHRLVRFQDR-AVQMFFATSA-N

物化性质

• 沸点：
  110-120 °C(Press: 0.05 Torr)
• 密度：
  0.929±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  16
• 可旋转键数：
  10
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2916190090

文献信息

• A method of controlling harmful insects
  申请人：NIHON BAYER AGROCHEM K.K.

  公开号：EP0564945A1

  公开（公告）日：1993-10-13

  The present invention relates to a process for the treatment of individual plants with solid shaped plant treatment agents which are introduced into the sap conduction paths of the plants, new solid shaped plant treatment agents and their production.

  本发明涉及一种用固体形状植物处理剂处理单株植物的工艺，这种处理剂被引入植物的汁液传导路径、新型固体形状植物处理剂及其生产。
• Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment
  申请人：Metabolon, Inc.

  公开号：US10267777B2

  公开（公告）日：2019-04-23

  Methods are described herein for small molecule biochemical profiling of an individual subject for diagnosis of a disease or disorder, facilitating diagnosis of a disease or disorder, and/or identifying an increased risk of developing a disease or disorder in the individual subject. Aberrant levels of small molecules present in a sample from an individual subject are identified and diagnostic information relevant to the individual subject is obtained based on the identified aberrant levels. The obtained diagnostic information includes one or more of an identification of at least one biochemical pathway associated with the identified subset of the small molecules having aberrant levels, an identification at least one disease or disorder associated with the identified subset of the small molecules having aberrant levels, and an identification of at least one recommended follow up test associated with the identified subset of the small molecules having aberrant levels.

  本文描述了对个体受试者进行小分子生化分析的方法，以诊断疾病或失调，促进疾病或失调的诊断，和/或确定个体受试者罹患疾病或失调的风险增加。确定个体受试者样本中存在的小分子的异常水平，并根据确定的异常水平获得与个体受试者相关的诊断信息。所获得的诊断信息包括：至少一个生化途径的鉴定，该生化途径与所鉴定的具有异常水平的小分子子集相关；至少一种疾病或紊乱的鉴定，该疾病或紊乱与所鉴定的具有异常水平的小分子子集相关；至少一种推荐的后续检测的鉴定，该检测与所鉴定的具有异常水平的小分子子集相关。
• Treating dry eye disorders
  申请人：Boston Biotechnology US CORP

  公开号：US10933111B2

  公开（公告）日：2021-03-02

  This disclosure is related to compositions and methods for treating dry dye disorders.

  本公开涉及治疗干染病的组合物和方法。
• SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT
  申请人：Metabolon, Inc.

  公开号：EP3129909A1

  公开（公告）日：2017-02-15
• PHARMACEUTICAL COMPOSITION AND METHODS
  申请人：Lipocine Inc.

  公开号：EP3185873A1

  公开（公告）日：2017-07-05